Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PLASOMA

Financiado

Cerrado

Cold plasma cures chronic wounds a sparkling solution

Plasmacure has been established in 2014 and currently employs 12 people. We have our own test facilities and technical staff. In 2018, we have received an A-round Investment of €2.2 million. Our mission statement is: We envision a... ver más

31/12/2023

PLASMACURE

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

PLASMACURE BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-12-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 69% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

PLASMACURE

2.50M€ | Lider

CERAMICA ELU

223.58K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

plasmaCare A small portable cold plasma device for the treatment of ch... 71K€ Cerrado

PlasmACT Plasma Medicine against Actinic Keratosis 2M€ Cerrado

kINPen Developing a high innovative portable cold plasma device for... 71K€ Cerrado

BIOCURE Novel Biomaterial for Improved and Cost efficient Wound Heal... 71K€ Cerrado

PHAS Development of a new generation of bioengineered bandages 191K€ Cerrado

PlaTechMedi A step towards new Plasma processing Technology for Medical... Cerrado

Duración del proyecto: 41 meses Fecha Inicio: 2020-07-07
Fecha Fin: 2023-12-31

Líder del proyecto

PLASMACURE BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Plasmacure has been established in 2014 and currently employs 12 people. We have our own test facilities and technical staff. In 2018, we have received an A-round Investment of €2.2 million. Our mission statement is: We envision a world where people no longer suffer from chronic wounds. In Europe, > 3 million people suffer from this condition. Chronic wounds cause pain, lead to amputations and loss of independence. Average costs are € 12,000 per wound. Currently, 25% of these wounds persist for months or even years. We have developed a medical device (PLASOMA) based on atmospheric cold plasma, which is air that contains highly reactive particles that kill bacteria and stimulate wound healing. It consists of disposable plasma pads and a pulser that emits high voltage pulses to induce the plasma. PLASOMA is the first cold plasma device with demonstrated clinical efficacy: In a first clinical study we showed that PLASOMA can cure at least half of the wounds that currently cannot be cured. PLASOMA increases quality of life, relieves the healthcare workforce and reduces antibiotics use. Should all hard-to-heal wounds be treated with PLASOMA, EU health care costs will decrease with > € 6 billion/yr. We expect to get CE in Q1 2020, after which sales will start. With the grant we will conduct a multinational clinical study to generate clinical efficacy data with which we can extend our first CE claim (reduce microbial load) to the claim that PLASOMA can cure chronic wounds, apply for reimbursement and get PLASOMA incorporated in the treatment guidelines. We will also develop pads with different sizes and shapes and make the pulser suitable for home use such that we can cover almost the entire wound market. With the equity, we can launch PLASOMA in 4 EU countries. We expect break even in 2024, and, in 2025, a turnover of € 30 million and 55 fte. Around 2026, we expect to enter a strategic partnership with a medical device company or bring Plasmacure to the stock exchange.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores